Literature DB >> 23392874

Effects of taurine supplementation upon food intake and central insulin signaling in malnourished mice fed on a high-fat diet.

Rafael L Camargo1, Thiago M Batista, Rosane A Ribeiro, Lício A Velloso, Antônio C Boschero, Everardo M Carneiro.   

Abstract

Feeding behavior is a major determinant of body composition, adiposity, and glucose homeostasis. Both obesity and malnutrition are risk factors for the metabolic syndrome and are associated with altered food intake. Here we assessed the effects of taurine (TAU) supplementation upon adiposity, food intake, and central insulin signaling in malnourished mice fed on a high-fat diet (HFD). Weaned male C57BL/6 mice were fed a control (14% protein-C) or a protein-restricted (6% protein-R) diet. After 6 weeks, both groups received or not HFD for 8 weeks (CH and RH). Half of the HFD groups were supplemented with 5% TAU (CHT and RHT). Both HFD groups were overweight and showed increased perigonadal and retroperitoneal fat pads. TAU supplementation attenuated obesity in CHT but not in RHT mice. HFD induced hypercholesterolemia and glucose intolerance, although only CH group presented fasting hyperglycemia. TAU supplementation also improved glucose homeostasis only in CHT mice. Western blot analysis showed a reduction of 55% in CH hypothalamic content of phosphorylated IRS-1 (pIRS-1) at basal condition compared with C. TAU treatment increased 35% Akt phosphorylation levels in CHT without modification in RHT hypothalamus. However, TAU supplementation did not alter hypothalamic pIRS-1 amount. CH and RH mice presented increased calorie intake that was normalized in CHT but not in RHT. In conclusion, mice fed on an HFD developed obesity, hypercholesterolemia, glucose intolerance, and increased calorie intake. TAU promoted increased hypothalamic insulin action only in CH mice which was linked to prevention of overfeeding, obesity, and glucose intolerance. Protein-restriction promoted metabolic damages that were not prevented by TAU supplementation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392874     DOI: 10.1007/978-1-4614-6093-0_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

Review 1.  Beneficial Effects of Taurine on Metabolic Parameters in Animals and Humans.

Authors:  Minkyung Bae; Kainat Ahmed; Jung-Eun Yim
Journal:  J Obes Metab Syndr       Date:  2022-06-07

2.  Scallop protein with endogenous high taurine and glycine content prevents high-fat, high-sucrose-induced obesity and improves plasma lipid profile in male C57BL/6J mice.

Authors:  Hanne Sørup Tastesen; Alison H Keenan; Lise Madsen; Karsten Kristiansen; Bjørn Liaset
Journal:  Amino Acids       Date:  2014-07       Impact factor: 3.520

3.  Protein malnutrition potentiates the amplifying pathway of insulin secretion in adult obese mice.

Authors:  Nayara Carvalho Leite; Flávia de Paula; Patrícia Cristine Borck; Jean Franciesco Vettorazzi; Renato Chaves Souto Branco; Camila Lubaczeuski; Antonio Carlos Boschero; Claudio Cesar Zoppi; Everardo Magalhães Carneiro
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

4.  Taurine Treatment Modulates Circadian Rhythms in Mice Fed A High Fat Diet.

Authors:  Ana Lucia C Figueroa; Hugo Figueiredo; Sandra A Rebuffat; Elaine Vieira; Ramon Gomis
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

5.  Effect of neuroactive nutritional supplementation on body weight and composition in growing puppies.

Authors:  Wei Wang; Melissa Brooks; Cari Gardner; Norton Milgram
Journal:  J Nutr Sci       Date:  2017-11-23

6.  Dietary intake of cod and scallop reduces atherosclerotic burden in female apolipoprotein E-deficient mice fed a Western-type high fat diet for 13 weeks.

Authors:  Ida-Johanne Jensen; Mari Walquist; Bjørn Liaset; Edel O Elvevoll; Karl-Erik Eilertsen
Journal:  Nutr Metab (Lond)       Date:  2016-02-02       Impact factor: 4.169

7.  Dietary sulfur amino acid restriction upregulates DICER to confer beneficial effects.

Authors:  Beatriz A Guerra; Bruna B Brandão; Silas S Pinto; Willian G Salgueiro; Evandro A De-Souza; Felipe C G Reis; Thiago M Batista; Vanessa Cavalcante-Silva; Vânia D'Almeida; Beatriz A Castilho; Everardo M Carneiro; Adam Antebi; William T Festuccia; Marcelo A Mori
Journal:  Mol Metab       Date:  2019-08-28       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.